XIGA MET 5/850MG

Xiga Met 5/850mg is a combination medication that contains two active ingredients: dapagliflozin and metformin. Dapagliflozin belongs to a class of medications called sodium-glucose cotransporter-2 (SGLT2) inhibitors, while metformin is a biguanide. This combination medicine is prescribed to manage blood sugar levels in individuals with type 2 diabetes mellitus.

Uses:

Xiga Met 5/850mg Tablet is primarily used for the following purposes:

1. Type 2 Diabetes: This medication is prescribed to control blood sugar levels in adults with type 2 diabetes mellitus. It helps lower blood glucose levels by increasing the excretion of glucose through the kidneys and reducing the production of glucose in the liver. Xiga Met 5/850mg Tablet is typically used alongside a proper diet and exercise regimen.

Side Effects:

Xiga Met 5/850mg Tablet may cause some side effects in certain individuals. The following side effects have been reported but may not be experienced by everyone:

1. Hypoglycemia (low blood sugar levels): Dapagliflozin in Xiga Met can increase the risk of hypoglycemia, especially when used in combination with other antidiabetic medications.
2. Urinary Tract Infections: Dapagliflozin may increase the risk of urinary tract infections in some individuals.
3. Genital Yeast Infections: Some females may experience genital yeast infections while taking dapagliflozin.
4. Increased Urination: Dapagliflozin is known to increase urination frequency.
5. Thirst or Dry Mouth: Increased urination can lead to feelings of thirst or dry mouth.
6. Dizziness or Lightheadedness: Some individuals may experience dizziness or lightheadedness, especially when standing up quickly.

It is important to note that this is not an exhaustive list of side effects. If you experience any unusual or persistent symptoms, it is essential to consult your healthcare provider for further evaluation.

When Not to Use:

Xiga Met 5/850mg Tablet should not be used under certain circumstances, including:

1. Type 1 Diabetes: This medication is not suitable for the treatment of type 1 diabetes.
2. Diabetic Ketoacidosis: It should not be used in individuals with diabetic ketoacidosis, a serious complication of diabetes characterized by high ketone levels in the blood.
3. Severe Kidney Impairment: If you have severe kidney impairment or end-stage renal disease, this medication may not be recommended.
4. Hypersensitivity: If you have had an allergic reaction to dapagliflozin, metformin, or any other ingredients present in Xiga Met 5/850mg Tablet, you should avoid using it.

It is crucial to inform your healthcare provider about your complete medical history, including any pre-existing conditions or allergies, before starting this medication.

Please note that the information provided here is a general overview and should not replace professional medical advice. Always consult your doctor or pharmacist for specific guidance tailored to your individual needs.